ClearBridge MLP and Midstream Total Return Fund Inc. CTR NYSE

NYSE • Financial Services • Asset Management • US • USD

ClearBridge MLP and Midstream Total Return Fund Inc. (CTR) has a consensus analyst rating of Sell, based on 2 analysts covering the stock. Of those, 0 recommend buying, 0 recommend holding, and 2 recommend selling.

Analyst Consensus — CTR

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

2 analysts

Price Targets

No price target data available.

People Also View

NIQ

Nuveen Intermediate Duration Quality Municipal Term Fund

$10.67

+0.66%

HQH

Tekla Healthcare Investors

$19.76

+1.96%

THQ

Tekla Healthcare Opportunities Fund

$17.81

-0.84%

LDP

Cohen & Steers Limited Duration Preferred and Income Fund, Inc.

$20.75

-0.24%

CHW

Calamos Global Dynamic Income Fund

$8.04

+1.77%

THW

Tekla World Healthcare Fund

$12.55

+0.97%

ETO

Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund

$29.27

+1.77%

MHN

BlackRock MuniHoldings New York Quality Fund, Inc.

$10.30

-0.39%

ClearBridge MLP and Midstream Total Return Fund Inc. CTR NYSE

Analyst Consensus — CTR

People Also View

Get Undervalued Stock Alerts